Home › Head and Neck Cancer › California › Santa Rosa
Head and Neck Cancer clinical trials in Santa Rosa, CA
4 studies for Head and Neck Cancer are looking for participants at sites in and around Santa Rosa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
- Kaiser Permanente-Santa Rosa, Santa Rosa
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Providence Medical Foundation, Santa Rosa
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- St Joseph Heritage Healthcare, Santa Rosa
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Providence Medical Foundation (site 209), Santa Rosa
About Head and Neck Cancer
Head and neck cancer includes cancers of the mouth, nose, sinuses, salivary glands, throat, and lymph nodes. Read the different symptoms of each type.
More about Head and Neck Cancer on MedlinePlus
Head and Neck Cancer trials in other cities
- Houston, TX30 studies
- Boston, MA22 studies
- New York City, NY21 studies
- Nashville, TN21 studies
- St. Louis, MO15 studies
- Dallas, TX12 studies
- Pittsburgh, PA11 studies
- Los Angeles, CA10 studies
- San Antonio, TX10 studies
- Washington, DC10 studies
- Baltimore, MD10 studies
- Durham, NC10 studies
Other studies in Santa Rosa
- Non-Small Cell Lung Cancer17 studies
- Lung Cancer11 studies
- Cancer (all types)11 studies
- Breast Cancer11 studies
- Colorectal Cancer11 studies
- Metastatic Cancer9 studies
- Prostate Cancer9 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer6 studies
- Endometrial Cancer6 studies
- Colon Cancer5 studies
- Stomach Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.